
LabGenius develops next-generation antibody and protein therapeutics to improve selectivity and tumor cell killing. The company applies a machine learning–driven evolution engine (EVA) that combines…

LabGenius develops next-generation antibody and protein therapeutics to improve selectivity and tumor cell killing. The company applies a machine learning–driven evolution engine (EVA) that combines…
Headquarters & founding: London; founded 2012
Core tech: EVA™ — ML-driven discovery engine combining machine learning, synthetic biology, and robotic automation
Focus: Discovery and optimisation of therapeutic antibodies for oncology (selectivity-enhanced antibodies, multispecific formats, T-cell engagers)
Recent financing: Series B £35M closed May 21, 2024 (led by M Ventures); company-reported total funding ~£58M
Therapeutic antibody discovery and optimisation for oncology
2012
Biotechnology Research
£35,000,000
Company reported this round brought total funding to ~£58M
“Includes corporate VC and top-tier venture investors (M Ventures lead; participation from Octopus Ventures, LG, Atomico, Kindred Capital, Lux Capital, Obvious Ventures)”
| Company |
|---|
At LabGenius Therapeutics ("LabGenius"), our mission is to discover the next generation of therapeutic antibodies by combining human and machine intelligence. To do this, we’ve pioneered the development of EVA™, state-of-the-art automated platform, enabling the closed-loop discovery of high-performing, non-intuitive antibody designs using proprietary, ML-grade datasets. For our wholly-owned therapeutic pipeline, we’re using our closed-loop discovery engine to establish a pipeline of highly selective T-cell engagers and ADCs for the treatment of solid tumours.
LabGenius has raised >£55M and is backed by top-tier investors, including M Ventures, Octopus Ventures, LG Corp, Atomico, Kindred Capital, Lux Capital and Obvious Ventures amongst others. The company is headquartered in London (UK) where we’ve established a cutting-edge antibody engineering facility. The company is staffed by a multidisciplinary team of more than 50 scientists and engineers.
You’ll be a pivotal member of the wet-lab team, serving as the technical lead for antibody binding characterization. This is a high-impact opportunity for a kinetics expert to not only execute assays but to build a world-class antibody binding platform from the ground up.
Your primary mission is to ensure that our ML models are fed with high-resolution, high-quality kinetic data. You won't just be running samples; you will be designing the workflows—using SPR (Surface Plasmon Resonance) and BLI (Biolayer Interferometry)—to transition our discovery pipeline from crude screening to clinical-grade lead optimization.
You’ll be a member of our antibody developability team, where you’ll ensure that the "best" binders also possess the biophysical properties required to become successful therapeutic products. You won't just be looking at how well an antibody binds; you’ll be stress-testing its "fitness" for clinical use, identifying liabilities like aggregation, instability, or poor solubility early in the pipeline.
Whatever your previous experience includes, you’ll inject passion and energy into everything you do. You’ll enjoy multi-disciplinary work, and you’ll have an endless hunger for knowledge, learning, and growth; all the qualities LabGenius Therapeutics celebrates!
Your role at LabGenius Therapeutics will be varied, with clear communication being critical to your day-to-day interactions with the team. Being able to integrate your workflow with other teams, along with the ability to share findings in an articulate manner, will help you to achieve success within this position.
This position is a full time laboratory-based role, on a 12 month fixed term contract.
What you’ll do in this role
What we’re looking for
Nice to have
What you’ll receive from us Aside from being part of our brilliant, purpose-driven team, you’ll also enjoy:
Financial 💸
Health 🍏
Time-Off ⏰
Wellbeing 💛
Team-building 🤝
Diversity & Inclusion We believe that diversity makes for innovative, exceptional teams.
We are an equal opportunity employer and do not discriminate based on gender, race, colour, religion or belief, national origin, age, sexual orientation, marital status, disability, or any other protected class.
If you don't feel like you meet every single requirement of this role, we still want to hear from you! We encourage you to apply, have a discussion with us about the role or others that we may have at LabGenius either now or in the future, together we can build more inclusive workplaces.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week